BR112020021101A2 - métodos de tratamento da dor neuropática - Google Patents
métodos de tratamento da dor neuropática Download PDFInfo
- Publication number
- BR112020021101A2 BR112020021101A2 BR112020021101-0A BR112020021101A BR112020021101A2 BR 112020021101 A2 BR112020021101 A2 BR 112020021101A2 BR 112020021101 A BR112020021101 A BR 112020021101A BR 112020021101 A2 BR112020021101 A2 BR 112020021101A2
- Authority
- BR
- Brazil
- Prior art keywords
- prolinamide
- oxy
- fluorophenyl
- phenyl
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862658347P | 2018-04-16 | 2018-04-16 | |
| US62/658,347 | 2018-04-16 | ||
| PCT/US2019/027158 WO2019204136A1 (en) | 2018-04-16 | 2019-04-12 | Methods of treating neuropathic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020021101A2 true BR112020021101A2 (pt) | 2021-02-23 |
Family
ID=68239826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020021101-0A BR112020021101A2 (pt) | 2018-04-16 | 2019-04-12 | métodos de tratamento da dor neuropática |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210154170A1 (https=) |
| EP (1) | EP3781157A4 (https=) |
| JP (1) | JP2021521227A (https=) |
| KR (1) | KR20210002472A (https=) |
| CN (1) | CN112367990A (https=) |
| AU (1) | AU2019255519A1 (https=) |
| BR (1) | BR112020021101A2 (https=) |
| CA (1) | CA3093401A1 (https=) |
| EA (1) | EA202092482A1 (https=) |
| IL (1) | IL277962A (https=) |
| MX (1) | MX2020010929A (https=) |
| SG (1) | SG11202008681PA (https=) |
| TW (2) | TW202245750A (https=) |
| WO (1) | WO2019204136A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
| TW200730494A (en) * | 2005-10-10 | 2007-08-16 | Glaxo Group Ltd | Novel compounds |
| GB201409851D0 (en) * | 2014-06-03 | 2014-07-16 | Convergence Pharmaceuticals | Diagnostic method |
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| JP2019537601A (ja) * | 2016-11-02 | 2019-12-26 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | 新規投薬レジメン |
-
2019
- 2019-04-12 KR KR1020207028395A patent/KR20210002472A/ko not_active Withdrawn
- 2019-04-12 BR BR112020021101-0A patent/BR112020021101A2/pt not_active Application Discontinuation
- 2019-04-12 EP EP19787899.4A patent/EP3781157A4/en not_active Withdrawn
- 2019-04-12 CN CN201980026095.5A patent/CN112367990A/zh not_active Withdrawn
- 2019-04-12 US US17/047,570 patent/US20210154170A1/en not_active Abandoned
- 2019-04-12 JP JP2020556855A patent/JP2021521227A/ja not_active Withdrawn
- 2019-04-12 SG SG11202008681PA patent/SG11202008681PA/en unknown
- 2019-04-12 EA EA202092482A patent/EA202092482A1/ru unknown
- 2019-04-12 WO PCT/US2019/027158 patent/WO2019204136A1/en not_active Ceased
- 2019-04-12 CA CA3093401A patent/CA3093401A1/en not_active Withdrawn
- 2019-04-12 AU AU2019255519A patent/AU2019255519A1/en not_active Withdrawn
- 2019-04-12 MX MX2020010929A patent/MX2020010929A/es unknown
- 2019-04-16 TW TW111111744A patent/TW202245750A/zh unknown
- 2019-04-16 TW TW108113193A patent/TWI803619B/zh not_active IP Right Cessation
-
2020
- 2020-10-12 IL IL277962A patent/IL277962A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021521227A (ja) | 2021-08-26 |
| MX2020010929A (es) | 2020-11-06 |
| TWI803619B (zh) | 2023-06-01 |
| US20210154170A1 (en) | 2021-05-27 |
| CA3093401A1 (en) | 2019-10-24 |
| AU2019255519A1 (en) | 2020-10-01 |
| IL277962A (en) | 2020-11-30 |
| SG11202008681PA (en) | 2020-10-29 |
| TW202245750A (zh) | 2022-12-01 |
| EA202092482A1 (ru) | 2021-03-30 |
| CN112367990A (zh) | 2021-02-12 |
| EP3781157A1 (en) | 2021-02-24 |
| KR20210002472A (ko) | 2021-01-08 |
| WO2019204136A1 (en) | 2019-10-24 |
| EP3781157A4 (en) | 2022-01-26 |
| TW201946619A (zh) | 2019-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022169734A (ja) | 医薬溶液、調製方法及び治療的使用 | |
| RU2338537C2 (ru) | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ | |
| Kaplan et al. | The medical management of fibrodysplasia ossificans progressiva: current treatment considerations | |
| US20060122127A1 (en) | Methods for reducing the side effects associated with mirtzapine treatment | |
| TW201028147A (en) | Dosage regimen of an S1P receptor agonist | |
| JP2018520187A (ja) | 神経変性疾患と関連する幻覚の予防および処置のために有用な５−ｈｔ２ａセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体 | |
| KR20150041635A (ko) | 시스타티오닌-γ-리아제(ＣＳＥ) 억제제 | |
| JP2007517049A (ja) | 再発性病状を治療するための組成物および方法 | |
| BR112020021101A2 (pt) | métodos de tratamento da dor neuropática | |
| JP2011121975A (ja) | 線維筋痛症に伴う疼痛を改善するための線維筋痛症に伴う疼痛改善用医薬組成物 | |
| JP2023011652A (ja) | 新規投薬レジメン | |
| EP3096790B1 (en) | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | |
| CA3252370A1 (en) | PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES USING ASPIRIN AND OTHER HIGHLY PENETRATING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) | |
| HK40046223A (en) | Methods of treating neuropathic pain | |
| RU2844953C1 (ru) | Способы лечения симптомов расстройства аутистического спектра | |
| JP2019123724A (ja) | 代謝型グルタミン酸作動性受容体サブタイプ２の正のアロステリック調節因子またはオルトステリックアゴニストを含む組み合わせ、およびそれらの使用 | |
| EP4475887A1 (en) | Methods of treating complex regional pain syndrome | |
| TW202502342A (zh) | 食慾素２受體促效劑用於改善睡眠期間之呼吸功能的用途 | |
| TW200838534A (en) | Treatment for irritable bowel syndrome | |
| JP2003221337A (ja) | 酢酸アミド誘導体を有効成分とする痴呆症治療剤 | |
| Tropea et al. | Treating Rett Syndrome: Current Approaches and New Treatments | |
| TW201919597A (zh) | 利用新斯的明（neostigmine）及nk-1拮抗劑治療重症肌無力之醫藥組合物及方法 | |
| WO2002051416A1 (fr) | Medicaments ameliorant les comportements de la vie courante chez des personnes atteintes de la maladie d'alzheimer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B10A | Cessation: cessation confirmed |